CER low impact; Big Data In-patient MR; FDA continuing Mini-Sentinel? (PRVR 7/28-31/2014)

Posted by on

Details

This week on Pharma Research VIDEO Report:
1) Experts agree the promise of comparative effectiveness research is having very little impact on healthcare decision making. 2) Dr. David Bates researched Big Data algorithms that he says can positively impact the expenditures on low-hanging fruit with in-patients. 3) The FDA must make a decision on whether or not to continue Mini-Sentinel, a program that investigates adverse events through queries to 18 health plan and insurance partners about private patient records.

Leave a Reply

You must be logged in to post a comment.